Discrepancy of Bone Metastases between F-18 FDG PET/CT and Bone Scan in a Patient with Prostate Cancer.
- Author:
Seung Jin CHOI
1
;
Chul Soo KIM
;
Sung Su BYUN
;
In Young HYUN
Author Information
1. Department of Nuclear Medicine, Inha University College of Medicine, Incheon, Korea. iyhyun@inha.ac.kr
- Publication Type:Case Report
- Keywords:
osseous metastases;
bone scan;
F-18 FDG PET/CT;
prostate cancer
- MeSH:
Abdomen;
Adenocarcinoma;
Aged;
Biopsy;
Coloring Agents;
Electrons;
Humans;
Lymph Nodes;
Neck;
Neoplasm Metastasis*;
Pelvis;
Positron-Emission Tomography and Computed Tomography*;
Prostate*;
Prostatic Neoplasms*
- From:Nuclear Medicine and Molecular Imaging
2006;40(5):275-278
- CountryRepublic of Korea
- Language:English
-
Abstract:
We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the detection of osseous metastases of prostate cancer.
